Transplantation of adipose‐derived mesenchymal stem cells into a murine model of passive chronic immune thrombocytopenia

Abstract

These findings constitute the first experimental evidence that ADSCs are efficacious in improving PLT levels and reducing the related Th cytokines mediating proinflammatory response in ITP mice, which may provide a scientific basis for using ADSCs as a new therapy for ITP.